Simplex Trading’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $556K | Sell |
8,600
-33,700
| -80% | -$2.38M | ﹤0.01% | 3135 |
|
|
2025
Q4 | $2.85M | Buy |
42,300
+16,600
| +65% | +$1.12M | ﹤0.01% | 1702 |
|
|
2025
Q3 | $1.88M | Sell |
25,700
-5,300
| -17% | -$352K | ﹤0.01% | 2391 |
|
|
2025
Q2 | $1.61M | Buy |
31,000
+8,900
| +40% | +$506K | ﹤0.01% | 2300 |
|
|
2025
Q1 | $1.41M | Sell |
22,100
-4,900
| -18% | -$285K | ﹤0.01% | 2373 |
|
|
2024
Q4 | $1.29M | Sell |
27,000
-22,500
| -45% | -$1.15M | ﹤0.01% | 2602 |
|
|
2024
Q3 | $2.83M | Buy |
49,500
+15,300
| +45% | +$877K | ﹤0.01% | 1973 |
|
|
2024
Q2 | $1.79M | Sell |
34,200
-31,100
| -48% | -$1.36M | ﹤0.01% | 2311 |
|
|
2024
Q1 | $2.66M | Buy |
65,300
+3,700
| +6% | +$139K | ﹤0.01% | 2128 |
|
|
2023
Q4 | $2.28M | Sell |
61,600
-17,000
| -22% | -$640K | ﹤0.01% | 2251 |
|
|
2023
Q3 | $3M | Buy |
78,600
+12,500
| +19% | +$512K | ﹤0.01% | 1733 |
|
|
2023
Q2 | $2.38M | Sell |
66,100
-22,400
| -25% | -$764K | ﹤0.01% | 1830 |
|
|
2023
Q1 | $3.38M | Buy |
88,500
+43,400
| +96% | +$2.04M | ﹤0.01% | 1540 |
|
|
2022
Q4 | $2.57M | Buy |
45,100
+32,600
| +261% | +$1.67M | ﹤0.01% | 1679 |
|
|
2022
Q3 | $494K | Buy |
12,500
+4,500
| +56% | +$199K | ﹤0.01% | 3486 |
|
|
2022
Q2 | $352K | Buy |
8,000
+2,500
| +45% | +$108K | ﹤0.01% | 3890 |
|
|
2022
Q1 | $219K | Sell |
5,500
-4,000
| -42% | -$142K | ﹤0.01% | 5033 |
|
|
2021
Q4 | $381K | Sell |
9,500
-33,100
| -78% | -$1.24M | ﹤0.01% | 4202 |
|
|
2021
Q3 | $1.97M | Buy |
42,600
+100
| +0.2% | +$4.18K | ﹤0.01% | 2155 |
|
|
2021
Q2 | $1.93M | Buy |
+42,500
| New | +$1.88M | ﹤0.01% | 2210 |
|
|
2021
Q1 | – | Sell |
-56
| Closed | -$239K | – | 9266 |
|
|
2020
Q4 | $239K | Sell |
56
-245
| -81% | -$8.81K | ﹤0.01% | 4370 |
|
|
2020
Q3 | $791K | Sell |
301
-913
| -75% | -$25.4K | ﹤0.01% | 2497 |
|
|
2020
Q2 | $3.25M | Buy |
1,214
+609
| +101% | +$13.7K | 0.01% | 1134 |
|
|
2020
Q1 | $1.09M | Sell |
605
-901
| -60% | -$17.1K | ﹤0.01% | 1800 |
|
|
2019
Q4 | $2.67M | Buy |
1,506
+1,146
| +318% | +$19.8K | 0.01% | 1244 |
|
|
2019
Q3 | $558K | Buy |
360
+160
| +80% | +$2.63K | ﹤0.01% | 2509 |
|
|
2019
Q2 | $343K | Buy |
200
+99
| +98% | +$1.6K | ﹤0.01% | 2934 |
|
|
2019
Q1 | $162K | Sell |
101
-26
| -20% | -$421 | ﹤0.01% | 3829 |
|
|
2018
Q4 | $185K | Sell |
127
-225
| -64% | -$3.59K | ﹤0.01% | 3234 |
|
|
2018
Q3 | $639K | Buy |
352
+296
| +529% | +$5.18K | ﹤0.01% | 2369 |
|
|
2018
Q2 | $94K | Sell |
56
-68
| -55% | -$1.29K | ﹤0.01% | 4365 |
|
|
2018
Q1 | $14K | Sell |
124
-28
| -18% | -$542 | ﹤0.01% | 3693 |
|
|
2017
Q4 | $85K | Sell |
152
-719
| -83% | -$13.2K | ﹤0.01% | 1931 |
|
|
2017
Q3 | $256K | Sell |
871
-389
| -31% | -$5.27K | 0.01% | 1039 |
|
|
2017
Q2 | $99K | Buy |
1,260
+369
| +41% | +$4.93K | ﹤0.01% | 1768 |
|
|
2017
Q1 | $77K | Sell |
891
-796
| -47% | -$10.1K | ﹤0.01% | 1975 |
|
|
2016
Q4 | $174K | Buy |
1,687
+701
| +71% | +$7.68K | 0.01% | 1144 |
|
|
2016
Q3 | $244K | Buy |
986
+280
| +40% | +$2.86K | 0.02% | 896 |
|
|
2016
Q2 | $81K | Sell |
706
-130
| -16% | -$1.28K | 0.01% | 1642 |
|
|
2016
Q1 | $160K | Buy |
836
+492
| +143% | +$4.63K | 0.01% | 1011 |
|
|
2015
Q4 | $106K | Buy |
344
+243
| +241% | +$3.87K | 0.01% | 1300 |
|
|
2015
Q3 | $24K | Sell |
101
-49
| -33% | -$984 | ﹤0.01% | 2614 |
|
|
2015
Q2 | $87K | Buy |
150
+29
| +24% | +$510 | 0.01% | 1298 |
|
|
2015
Q1 | $35K | Sell |
121
-27
| -18% | -$389 | ﹤0.01% | 1826 |
|
|
2014
Q4 | $7K | Buy |
+148
| New | +$1.31K | ﹤0.01% | 2843 |
|
Other funds holding HALO
VCM
VPM
Simplex Trading's HALO Position: Q3 2025 in Review
Simplex Trading sold out of Halozyme (HALO) in Q3 2025, closing a stake of 1,069 shares — an estimated $71K sold.
Simplex Trading first reported a position in HALO in Q1 2015 and held it in 20 quarters. The position peaked at $870K in Q3 2020. 602 funds tracked by Wall St. Rank hold HALO as of Q3 2025.
- Simplex Trading reported no remaining Halozyme position as of Q3 2025 after selling out during the quarter.
- Simplex Trading sold 1,069 Halozyme shares in Q3 2025, an estimated $71K.
- Simplex Trading first reported a position in Halozyme in Q1 2015 and held it in 20 quarters.
- Simplex Trading's Halozyme position peaked at $870K in Q3 2020.
- 602 funds tracked by Wall St. Rank held Halozyme as of Q3 2025.
Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.